TAK-715 is a potent p38 MAPK inhibitor. which displays potent inhibitory activity and no inhibitory activity for major CYPs, including CYP3A4.
For research use only. We do not sell to patients.
| Name | TAK-715 |
|---|---|
| Iupac Chemical Name | N-(4-(2-ethyl-4-(m-tolyl)thiazol-5-yl)pyridin-2-yl)benzamide |
| Synonyms | TAK715, TA 715, TAK715 |
| Molecular Formula | C24H21N3OS |
| Molecular Weight | 399.51 |
| Smile | O=C(NC1=NC=CC(C2=C(C3=CC=CC(C)=C3)N=C(CC)S2)=C1)C4=CC=CC=C4 |
| InChiKey | HEKAIDKUDLCBRU-UHFFFAOYSA-N |
| InChi | InChI=1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28) |
| CAS Number | 303162-79-0 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |